Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)

Gynecologic Oncology
Stefan KommossFriedrich Kommoss

Abstract

Proliferative activity (PA) may be an indicator of a neoplasm's malignant potential, and it has been described as a prognostic factor in different malignant tumors. It was our aim to study the prognostic significance of PA defined by Ki-S5 and Ki-S2 immunohistochemical staining in a large homogeneously treated cohort with primary advanced-stage ovarian carcinomas. Immunohistochemical detection of PA was performed using monoclonal Ki-S5 and Ki-S2 antibodies and standard immunostaining protocols. Kaplan-Meier survival analysis and Cox regression multivariate analysis were performed. High Ki-S5 PA was associated with a better prognosis. This finding was statistically significant after univariate and multivariate analysis. A similar trend was found in the subgroup of completely debulked patients. No prognostic effect of Ki-S2 PA could be detected in the present study. High Ki-S5 PA is an indicator of a more favourable prognosis in patients with advanced ovarian carcinomas. Antiproliferative chemotherapy may be more effective in tumors which are highly proliferative, possibly due to an increased chemosensitivity.

References

Aug 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J L GuesdonS Avrameas
Aug 1, 1990·Journal of the National Cancer Institute·E K RowinskyR C Donehower
Jun 1, 1989·British Journal of Obstetrics and Gynaecology·W S Wong, M H Tattersall
Apr 1, 1996·The Journal of Pathology·J BöhmH Höfler
Aug 1, 1997·Journal of the American Academy of Dermatology·P RudolphR Parwaresch
Feb 26, 1999·Journal of the National Cancer Institute·P RudolphR Parwaresch
Aug 26, 1999·The British Journal of Ophthalmology·J M MAcKENZIE
Sep 4, 2003·Journal of the National Cancer Institute·Andreas du BoisUNKNOWN Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group
Jan 28, 2005·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Shunji MitaToshiyuki Takeshita
Jun 22, 2005·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Ibrahim KhalifehRouba Ali-Fehmi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.